Oriana Papin-Zoghbi, AOA Dx CEO
October 11, 2023 08:00 AM EDTUpdated 09:03 AM
Financing
Diagnostics

Ex­clu­sive: Liq­uid-biop­sy start­up clos­es $17M to fund ovar­i­an can­cer di­ag­nos­tic test

Anna Brown

News Reporter

Liq­uid biop­sy start­up AOA Dx has col­lect­ed $17 mil­lion to sup­port the de­vel­op­ment of its di­ag­nos­tic test for ovar­i­an can­cer as well as the plat­form …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Evotec gains on Halozyme's takeover pro­pos­al

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Adap­ti­m­mune to 're­de­fine' it­self as a sar­co­ma biotech, cuts a third of staffers

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times